SRP9 and cancer: These results are consistent with a model in which TE mobility is broadly similar in cancer cells and in the germline, perhaps because some genetic determinants of TE mobility, such as intact ORFs and intact protein-binding sequences (for example, SRP9/14 motifs in Alus [48]), are independent of cell type.